8-K/A 1 y44717a1e8-ka.txt AMENDMENT #1 TO 8-K: REGENERON PHARMACEUTICALS 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------------------------------------------------------------- FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 25, 2001 Regeneron Pharmaceuticals, Inc. -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New York 333-31764 13-3444607 --------------- ------------ ------------------ (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) incorporation)
777 Old Saw Mill River Rd, Tarrytown NY, 10591-6707 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) 914-347-7000 -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) 2 Regeneron Pharmaceuticals, Inc. Current Report on Form 8-K/A Items 1-4. Not applicable. Item 5. Other Events. On January 25, 2001, the Registrant issued a revised press release to correct a minor typographical error contained in the press release issued earlier in the day. The revised press release is attached hereto as Exhibit 99.1. Item 6. Not Applicable. Item 7. Financial Statements and Exhibits. The following exhibits are furnished in accordance with the provisions of Item 601 of Regulation S-K:
Exhibit No. Description ----------- ----------- 99.1 Press Release, dated January 25, 2001
Item 8. Not Applicable. 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned's duly authorized signatory. Dated: January 26, 2001 REGENERON PHARMACEUTICALS, INC. By: /s/ Murray A. Goldberg ---------------------------- Name: Murray A. Goldberg Title: Senior Vice President, Finance & Administration, Chief Financial Officer, Treasurer, and Assistant Secretary 3 4 EXHIBIT INDEX
Exhibit No. Description ----------- ----------- 99.1 Press Release, dated January 25, 2001.
4